Eagle Pharmaceuticals, Inc.
(NASDAQ : EGRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. -2.78%81.572.1%$224.58m
SAVACassava Sciences, Inc. 1.28%9.890.0%$172.34m
JAZZJazz Pharmaceuticals Plc 0.30%138.492.4%$166.92m
HZNPHorizon Therapeutics Plc -5.84%75.125.8%$154.72m
MRNSMarinus Pharmaceuticals, Inc. -8.16%11.037.8%$123.76m
CORTCorcept Therapeutics, Inc. -1.82%16.755.5%$117.44m
VRXValeant Pharmaceuticals International, Inc. -3.11%15.2514.1%$89.73m
BHCBausch Health Cos., Inc. -3.11%15.250.0%$60.40m
MYOKMyoKardia, Inc. 0.60%130.161.8%$58.62m
AMRNAmarin Corp. Plc 0.00%3.681.5%$54.26m
ARGXargenx SE -1.07%243.210.0%$54.13m
SAGESAGE Therapeutics, Inc. 0.25%60.158.6%$46.34m
GWPHGW Pharmaceuticals Plc -1.44%98.566.2%$41.20m
AXSMAxsome Therapeutics, Inc. 0.23%77.771.9%$39.42m
PRGOPerrigo Co. Plc 0.31%45.516.8%$36.94m

Company Profile

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.